By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – ChanTest is collaborating with the US Food and Drug Administration to develop assays to improve prediction of cardiac safety, the company announced on Thursday.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.
The new Riken president outlines some of his plans for the institute.
The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.
An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.